Bonito Biosciences
Waltham
About Bonito Biosciences
Bonito Biosciences is a biotechnology research firm specializing in tissue-selective drug delivery for oligonucleotides and macromolecules.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $9.0M
- Funding stage: Seed
- Last round: Seed (May 2024)
- Website: bonitobio.com
Industries & Categories
Biotechnology, Medical, Product Research
Social Profiles
Canonical: https://fsome.com/organization/bonito-biosciences-107696 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.